Lapatinib in Women With Metastatic Breast Cancer Who Have Failed Prior Antihormone Therapy
Status:
Terminated
Trial end date:
2018-08-20
Target enrollment:
Participant gender:
Summary
Hormone receptor positive breast cancer is the most common type of breast cancer, comprising
70-80% of all breast cancers. Endocrine therapy is the main type of initial treatment for
patients with your type of breast cancer. Endocrine therapy is treatment that tries to
remove, or block certain hormones from binding to the cancer cells and thus slow or stop the
growth of cancer. Although most patients with your type of breast cancer respond initially to
endocrine therapies, it can lose its effectiveness. New therapies for this type of cancer are
needed.
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas University of Kansas Medical Center